Clinical trial
Integrated Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes: a Cross-sectional Study Protocol
NCT07512934 is registered in ClinicalTrials.gov with West Kazakhstan Marat Ospanov Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Integrated Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes: a Cross-sectional Study Protocol
- Lead sponsor
- West Kazakhstan Marat Ospanov Medical University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 7, 2025
- Completion date
- December 1, 2026
- Enrollment
- 310 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
exocrine pancreatic insufficiency (epi), pancreatogenic diabetes mellitus, type 2 diabetes mellitus (t2dm)